You will lead a bone marrow transplant program that ranks among the Top 5 busiest in the country, performing more than 50 transplants annually. This volume creates the clinical complexity and case diversity that keeps your skills sharp while generating the outcomes data necessary for academic productivity and program reputation. The program has achieved one of the lowest mortality rates in the nation, a testament to the clinical protocols, team coordination, and institutional support already in place.
Your patient population consists exclusively of pediatric and young adult patients up to age 25. You will treat children and adolescents with leukemias, lymphomas, solid tumors, brain tumors, and rare cancers, as well as patients requiring transplant for benign hematologic conditions. The program's robust hematology service covers the full spectrum of benign hematologic disorders, sickle cell disease, hemostasis, and thrombosis, giving you exposure to cases beyond malignancy.
The call structure respects your time while ensuring patients receive expert coverage around the clock. Currently running at 1:4, the rotation will transition to 1:6 as the team expands. Once you build the team to seven physicians, you as Director will be removed from the call rotation entirely. Call weeks are taken one week at a time rather than scattered individual days, allowing you to plan your personal life with predictability.
Primary inpatient coverage falls to hospitalists, residents, and fellows. Your BMT faculty team provides consultative support rather than serving as the frontline for every admission. This model keeps you focused on the complex transplant decisions that require your expertise while the broader care team manages day-to-day inpatient needs. The collaborative culture means your colleagues provide thorough sign-out and respect boundaries during off-time.
Six APPs work alongside you, each carrying their own patient panel. This level of support means routine follow-ups, standard protocol management, and day-to-day patient questions flow through experienced providers who know your patients and protocols. Your time stays focused on the clinical decisions that require physician-level judgment: complex transplant planning, managing complications, and guiding families through difficult treatment decisions.
Patient care at the Center for Cancer & Blood Disorders operates through a truly interdisciplinary model. You will work alongside dedicated specialists who share responsibility for your patients' wellbeing beyond their transplant care. The support team includes psychiatry, therapists, pathologists, social workers, nutritionists, psychologists, and child life specialists. This comprehensive team approach means you can focus on the medical complexity of transplant while knowing your patients' emotional, developmental, and social needs receive expert attention.
The hospital uses Allscripts Sunrise, the same EMR platform used by Mayo Clinic. The system supports the clinical workflows of a high-acuity transplant program and integrates with the broader Phoenix Children's network across all three hospital locations.
Phoenix Children's wants you to lead the initiative toward generating their own CAR T-cells. The institution has contracts and funding in place to build a research arm focused on immune therapy, including support for a PCH-controlled cell therapy laboratory. This is not a distant aspiration; the infrastructure and financial commitment exist today, waiting for a leader to drive the vision forward. If CAR T-cell therapy and cellular immunotherapy represent the future of pediatric oncology, this position places you at the center of that future.
More than 100 clinical trials are currently in progress across leukemias, lymphomas, solid tumors, brain tumors, and rare cancers. As a member of the Children's Oncology Group (COG), the program maintains access to national protocols and collaborative research networks. Research affiliations with the University of Arizona College of Medicine, Mayo Clinic, City of Hope's Translational Genomics Research Institute (TGen), and Arizona State University's Department of Bioengineering provide pathways for both clinical and translational research.
The institution has historically sponsored unfunded research sparingly but has indicated openness to supporting research for this position. Neither time nor money will limit what you can accomplish. If you bring laboratory interests, the department and division will support those ambitions. Philanthropic support for the program is strong, creating additional funding pathways beyond traditional grants.
This clinical environment offers the volume and complexity to maintain your procedural expertise, the support structure to protect your time, and the institutional backing to pursue the innovations that will define the next chapter of pediatric transplant medicine.